FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Elin Karlsson

Research Profile

Physiology

Disorders

Anatomy

Tumor Cells, Cultured

Concepts & Ideas

Occupations

Radiation Oncology

Chemicals & Drugs

Procedures

Neoadjuvant Therapy

Genes & Molecular Sequences

Genome, Human

Co-author Network

Publications

TOP 3
Elin Karlsson; Ulla Delle; Anna Danielsson; Björn Olsson; Frida Abel; Per Karlsson; Khalil Helou
Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer.
Elin Karlsson; Anna Danielsson; Ulla Delle; Björn Olsson; Per Karlsson; Khalil Helou
Chromosomal changes associated with clinical outcome in lymph node-negative breast cancer.
Khalil Helou; Hesed Padilla-Nash; Danny Wangsa; Elin Karlsson; Lovisa Osterberg; Per Karlsson; Thomas Ried; Turid Knutsen
Comparative genome hybridization reveals specific genomic imbalances during the genesis from benign through borderline to malignant ovarian tumors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Elin Karlsson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Elin Karlsson; Ulla Delle; Anna Danielsson; Björn Olsson; Frida Abel; Per Karlsson; Khalil Helou
Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer.
BMC cancer 2008;8():254.
2007: Elin Karlsson; Anna Danielsson; Ulla Delle; Björn Olsson; Per Karlsson; Khalil Helou
Chromosomal changes associated with clinical outcome in lymph node-negative breast cancer.
Cancer genetics and cytogenetics 2007;172(2):139-46.
2006: Khalil Helou; Hesed Padilla-Nash; Danny Wangsa; Elin Karlsson; Lovisa Osterberg; Per Karlsson; Thomas Ried; Turid Knutsen
Comparative genome hybridization reveals specific genomic imbalances during the genesis from benign through borderline to malignant ovarian tumors.
Cancer genetics and cytogenetics 2006;170(1):1-8.
2005: Anna Danielsson; Elin Karlsson; Ulla Delle; Khalil Helou; Claes Mercke
The biological effect of pentoxifylline on the survival of human head and neck cancer cells treated with continuous low and high dose-rate irradiation.
Journal of cancer research and clinical oncology 2005;131(7):459-67.
2000: Thomas Björk-Eriksson; C West; Elin Karlsson; Claes Mercke
Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancers.
International journal of radiation oncology, biology, physics 2000;46(1):13-9.
1999: Thomas Björk-Eriksson; C West; A Nilsson; Bengt Magnusson; Marie Svensson; Elin Karlsson; Nicholas J Slevin; Rolf Lewensohn; Claes Mercke
The immunohistochemical expression of DNA-PKCS and Ku (p70/p80) in head and neck cancers: relationships with radiosensitivity.
International journal of radiation oncology, biology, physics 1999;45(4):1005-10.
1999: Thomas Björk-Eriksson; C M West; E Cvetskovska; Marie Svensson; Elin Karlsson; Bengt Magnusson; Nicholas J Slevin; Staffan Edström; Claes Mercke
The lack of correlation between proliferation (Ki-67, PCNA, LI, Tpot), p53 expression and radiosensitivity for head and neck cancers.
British journal of cancer 1999;80(9):1400-4.
1998: Thomas Björk-Eriksson; C West; Elin Karlsson; Claes Mercke
Discrimination of human tumor radioresponsiveness using low-dose rate irradiation.
International journal of radiation oncology, biology, physics 1998;42(5):1147-53.
1998: Thomas Björk-Eriksson; C M West; Elin Karlsson; Nicholas J Slevin; Susan E Davidson; R D James; Claes Mercke
The in vitro radiosensitivity of human head and neck cancers.
British journal of cancer 1998;77(12):2371-5.